Storia in 12 fonti

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

independent.co.ukStai leggendo1 mese fa

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

originale

apnews.com

Timeline cronologica

martedì 16 giugno 2026·biopharmadive.com
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this…
martedì 16 giugno 2026·medpagetoday.com
FDA Staff Weighs In on Potential First mRNA Flu Shot
Moderna's novel vaccine was at the center of dustup with agency earlier this year

1 mese fa

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic.

Leggi questa versione → originale

sciencealert.com1 mese fa

New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel

Moderna's mRNA flu vaccine mFlusiva received unanimous FDA panel approval with 27% case reduction in a 40,000-person trial. Faster mRNA manufacturing enables rapid adaptation if flu strains mutate, potentially preventing thousands of senior hospitalizations.

Leggi questa versione → originale

nbcnews.com1 mese fa

FDA panel recommends Moderna’s mRNA flu shot for older adults

The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.

Leggi questa versione → originale

biopharmadive.com1 mese fa

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine

Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this year.

Leggi questa versione → originale

npr.org1 mese fa

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

Leggi questa versione → originale

martedì 16 giugno 2026·

endpoints.news

FDA raises efficacy questions for Moderna’s flu vaccine but no dire flags

FDA briefing documents offered measured support for Moderna's mRNA-1010 flu vaccine ahead of Thursday adcomm, flagging B/Victoria strain gap but calling reactogenicity

mercoledì 17 giugno 2026·

benzinga.com

FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)

Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.

giovedì 18 giugno 2026·

biopharmadive.com

Moderna flu vaccine wins unanimous support from FDA panel

The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.

giovedì 18 giugno 2026·

npr.org

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

giovedì 18 giugno 2026·

apnews.com

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic.

giovedì 18 giugno 2026·

independent.co.uk

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

giovedì 18 giugno 2026·

medpagetoday.com

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and up

giovedì 18 giugno 2026·

statnews.com

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.

giovedì 18 giugno 2026·

nbcnews.com

FDA panel recommends Moderna’s mRNA flu shot for older adults

The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.

venerdì 19 giugno 2026·

arstechnica.com

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

In February, a Trump official refused to review the vaccine.

venerdì 19 giugno 2026·

sciencealert.com

New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel

WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S.

venerdì 19 giugno 2026·

expansion.com

Expertos estadounidenses respaldan la primera vacuna de ARN mensajero contra la gripe de Moderna

Un comit� de asesores independientes de la Administraci�n de Alimentos y Medicamentos de Estados Unidos (FDA, en sus siglas inglesas) recomienda la aprobaci�n de la primera...

venerdì 19 giugno 2026·

benzinga.com

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR

Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

Timeline cronologica

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine

FDA Staff Weighs In on Potential First mRNA Flu Shot

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel

FDA panel recommends Moderna’s mRNA flu shot for older adults

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine

Key FDA committee unanimously recommends its first vaccine since 2023

FDA raises efficacy questions for Moderna’s flu vaccine but no dire flags

FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)

Moderna flu vaccine wins unanimous support from FDA panel

Key FDA committee unanimously recommends its first vaccine since 2023

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

FDA panel recommends Moderna’s mRNA flu shot for older adults

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel

Expertos estadounidenses respaldan la primera vacuna de ARN mensajero contra la gripe de Moderna

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR